Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ROSE LI AND ASSOCIATES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-02 to 2026-09-01
Current total value of award: $20000
Description: HIGH RISK CLINICAL TRIALS REQUIRE DATA AND SAFETY MONITORING. CONTINUATION OF RLA'S OPERATIONAL SERVICES IS NECESSARY TO MAINTAIN DATA INTEGRITY. "SAFETY" MONITORING IS MISSION CRITICAL IN TERMS OF CLINICAL TRIALS OVERSIGHT.